Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10597514 | 0.88 | CYP3A4 (0.43) | CYP3A4MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL17444458 | 0.86 | MEN1 (0.46) | CYP3A4MEN1KMT2ATDP1L3MBTL1 | |
| SCHEMBL474925 | 0.84 | ALDH1A1 (0.57) | CYP3A4MEN1KMT2ATDP1L3MBTL1 | |
| Allylbenzene SCHEMBL318129 | 0.82 | MAOB (0.57) | CYP3A4MEN1KMT2ATDP1L3MBTL1 | |
| Hydrogen Peroxide SCHEMBL7816450 | 0.82 | ALDH1A1 (0.58) | CYP3A4MEN1KMT2ATDP1L3MBTL1 | |
| Hydrogen Peroxide SCHEMBL5496256 | 0.82 | ALDH1A1 (0.58) | CYP3A4MEN1KMT2ATDP1L3MBTL1 | |
| Allylbenzene SCHEMBL2478260 | 0.79 | MAOB (0.60) | CYP3A4MEN1KMT2AALDH1A1SMN1; SMN2 | |
| Allylbenzene SCHEMBL21274 | 0.79 | — | — | |
| Allylbenzene SCHEMBL10325179 | 0.79 | MAOB (0.60) | CYP3A4MEN1KMT2AALDH1A1SMN1; SMN2 | |
| Phenol SCHEMBL9577264 | 0.78 | XDH (0.52) | CYP3A4MEN1KMT2ATDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102686777-A | Process for sintering nanoparticles at low temperatures | YISSUM RES DEV CO | 2012-09-19 | — | — | CN | claimed |
| EP-0864564-A1 | Method for the preparation of alpha-bromolactam derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | claimed |
| EP-2953918-B1 | ALKYL TRITYL PHENYL ETHERS | ROHM & HAAS (US) | 2018-07-25 | — | — | EP | disclosed |
| CN-105579427-B | Alkyl trityl phenyl ethers | 罗门哈斯公司 | 2017-06-06 | — | — | CN | disclosed |
| US-9587187-B2 | Alkyl trityl phenyl ethers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-03-07 | — | — | US | disclosed |
| CN-105579427-A | Alkyl trityl phenyl ethers | ROHM & HAAS | 2016-05-11 | — | — | CN | disclosed |
| US-20160040082-A1 | ALKYL TRITYL PHENYL ETHERS | ROHM AND HAAS COMPANY (US) | 2016-02-11 | — | — | US | disclosed |
| EP-2953918-A1 | ALKYL TRITYL PHENYL ETHERS | Dow Global Technologies LLC (US) | 2015-12-16 | — | — | EP | disclosed |
| WO-2014165776-A1 | ALKYL TRITYL PHENYL ETHERS | ANGUS CHEMICAL COMPANY (US) | 2014-10-09 | — | — | WO | disclosed |
| CN-102686777-A | Process for sintering nanoparticles at low temperatures | YISSUM RES DEV CO | 2012-09-19 | — | — | CN | disclosed |
| CN-101233137-A | Macrocylic inhibitors of hepatitis c virus | TIBOTEC PHARM LTD (IE) | 2008-07-30 | — | — | CN | disclosed |
| US-6114541-A | Method for the preparation of α-Bromo-Lactam derivatives | HOFFMANN-LA ROCHE INC. (US) | 2000-09-05 | — | — | US | disclosed |
| EP-0864564-A1 | Method for the preparation of alpha-bromolactam derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160040082-A1 | ALKYL TRITYL PHENYL ETHERS | ALK, KCNQ1, KCNH3 | CYP3A4 811/4885MEN1 1261/4885KMT2A 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.